Dr. Brandon Wilder is focused on finding lasting, safe and effective ways to both prevent and treat malaria, which infected 249 million people and killed 608,000 worldwide in 2022. #ResearchWeek #OHSUResearch news.ohsu.edu/2024/05/10/imm…

CMV-based vaccines induce T cells recognizing cancer antigens via conserved MHC-E molecules Science Advances Louis Picker #Früh science.org/doi/10.1126/sc…

VGTI is happy to share that one of our labs, using a CMV-based cancer vaccine, has just been published in Science Advances! Congrats to Dr Klaus Frueh and his team. This paper is the result of a wonderful, collaboration between OHSU, Mt. Sinai and Vir Biotechnology. Read the

The Cliffe lab is hiring a lab specialist or technician. Our current technician is leaving for grad school 👏. The post is well-suited for anyone who would like a few years of experience before grad school or for someone who would like to stay in a position for longer. Pls RT

Apply here for the lab technician post - uva.wd1.myworkdayjobs.com/UVAJobs/job/Ch… And here for a lab specialist job uva.wd1.myworkdayjobs.com/UVAJobs/job/Ch…

60 days until the #HerpeticLegion reactivates at #IHW2024

Last week, the VGTI renamed our building in honor of our late founding director, who passed earlier this year. Dr Nelson forged VGTI into an international powerhouse in vaccine research, contributing to many profound discoveries in immunology. Our new name, The Jay Nelson

Amazing work Klaus Früh and team! They developed a platform for cytomegalovirus-based vaccines, which shows promise as a “shield” against cancer. Read more here: news.ohsu.edu/2024/05/28/ohs…

A postdoc position is available in our lab to work on the impact of herpes simplex virus infection on the nervous system. Great opportunity to gain expertise in different neuronal models of infection and an animal model of HSV neurogenerative disease.

“The idea is that by throwing a type of T cell against the cancer that the cancer hasn’t seen before, it will have a harder time evading immunity.” - Dr. Klaus Früh on an HIV vaccine showing promise for cancer prevention: bit.ly/4aGlbyx #OHSUResearch

Klaus Früh PhD, Scott Hansen PhD, and Louis Picker MD, have a new paper in Science Advances which shows the OHSU developed platform for cytomegalovirus-based vaccines. It shows promise as a “shield” against cancer. Read the article here: news.ohsu.edu/2024/05/28/ohs…

Now officially published nature . Led by the one and only Yaara Finkel. By engineering HCMV to express sgRNA libraries directly from the viral genome, we developed VECOS (Virus Encoded CRISPR-based direct readOut System).

Congratulations to Corcoran Lab on a very deserving mid career mentor award from the Canadian virology community Canadian Society for Virology Nominated by her trainees illustrates the impact she has made. Jenn, you are a fantastic role model and some I aspire to be like. Can you mentor me too?

Latest from the lab— online today journals.plos.org/plospathogens/…

Great job to Rebecca Skalsky and team! Read more about their findings related to the Epstein-Barr virus below.

Great job Brandon Wilder and team! Read more about their recent findings on antimalarial drugs here: pubmed.ncbi.nlm.nih.gov/38862127

Interested in a PhD in emerging viruses and viral phase separation using imaging, biophysics, structural biology, and AI? We are part of the new CRC 1648 consortium! Our PhD position starts October 1st or later. Please have a look at the job posting: tinyurl.com/yd4tudp7

Congratulations to Dan Streblow Ph.D. and colleague for receiving the 2025 PMedIC Innovation award! 🎉

Congrats to our PhD student Enrico Caragliano for one of the best thesis in the chemistry department of UHH! Amazing colab with the Brune lab at LIV!